Publication Name	World Journal of Gastroenterology
Manuscript ID	88517
Country	China

Received	2023-09-27 07:51
Peer-Review Started	2023-09-27 07:53
To Make the First Decision
Return for Revision	2023-12-04 19:48
Revised	2023-12-18 15:25
Second Decision	2024-01-25 03:03
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-01-25 05:04
Articles in Press	2024-01-25 05:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-02-20 00:53
Publish the Manuscript Online	2024-02-26 13:28

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Study
Article Title	Transcatheter arterial chemoembolization combined with PD-1 inhibitors and Lenvatinib for hepatocellular carcinoma with portal vein tumor thrombus
Manuscript Source	Unsolicited Manuscript
All Author List	Hong-Xiao Wu, Xiao-Yan Ding, Ya-Wen Xu, Ming-Hua Yu, Xiao-Mi Li, Na Deng and Jing-Long Chen
ORCID	Author(s) ORCID Number Hong-Xiao Wu http://orcid.org/0000-0003-4425-7214 Jing-Long Chen http://orcid.org/0000-0003-1640-7115
Funding Agency and Grant Number
Corresponding Author	Jing-Long Chen, Doctor, Chief Doctor, Cancer Center, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshun East Street, Chaoyang District, Beijing 100015, China. cjl6412@ccmu.edu.cn
Key Words	Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Lenvatinib; PD-1 inhibitor; Portal vein tumor thrombus
Core Tip	Hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) has a poor prognosis and treatment responses. Assessment of its survival has important clinical implications. Through our research, we discovered that a triplet regimen of PD-1 inhibitor/TACE/Lenvatinib was safe and well-tolerated as well as exhibited favorable efficacy over the TACE/Lenvatinib regimen for advanced-stage HCC comorbid with PVTT.
Publish Date	2024-02-26 13:28
Citation	Wu HX, Ding XY, Xu YW, Yu MH, Li XM, Deng N, Chen JL. Transcatheter arterial chemoembolization combined with PD-1 inhibitors and Lenvatinib for hepatocellular carcinoma with portal vein tumor thrombus. World J Gastroenterol 2024; 30(8): 843-854
URL	https://www.wjgnet.com/1007-9327/full/v30/i8/843.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i8.843

Full Article (PDF)	WJG-30-843-with-cover.pdf
Full Article (Word)	WJG-30-843.docx
Manuscript File	88517_Auto_Edited-YJP.docx
Answering Reviewers	88517-Answering reviewers.pdf
Audio Core Tip	88517-Audio core tip.mp4
Biostatistics Review Certificate	88517-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	88517-Conflict-of-interest statement.pdf
Copyright License Agreement	88517-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	88517-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	88517-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	88517-Language certificate.pdf
Peer-review Report	88517-Peer-review(s).pdf
Scientific Misconduct Check	88517-Bing-Lin C-2.png
Scientific Editor Work List	88517-Scientific editor work list.pdf